The V2 receptor antagonist tolvaptan raises cytosolic calcium and prevents AQP2 trafficking and function: an in vitro and in vivo assessment
about
Astroglial Modulation of Hydromineral Balance and Cerebral Edema.Activation of Calcium-Sensing Receptor increases intracellular calcium and decreases cAMP and mTOR in PKD1 deficient cells.Activation of the Calcium-Sensing Receptor Corrects the Impaired Mitochondrial Energy Status Observed in Renal Polycystin-1 Knockdown Cells Modeling Autosomal Dominant Polycystic Kidney Disease
P2860
The V2 receptor antagonist tolvaptan raises cytosolic calcium and prevents AQP2 trafficking and function: an in vitro and in vivo assessment
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
The V2 receptor antagonist tol ...... n vitro and in vivo assessment
@en
type
label
The V2 receptor antagonist tol ...... n vitro and in vivo assessment
@en
prefLabel
The V2 receptor antagonist tol ...... n vitro and in vivo assessment
@en
P2093
P2860
P356
P1476
The V2 receptor antagonist tol ...... n vitro and in vivo assessment
@en
P2093
Alberta Zallone
Ari Geller
Giovanna Valenti
Grazia Tamma
Roberto Tamma
P2860
P304
P356
10.1111/JCMM.13098
P577
2017-03-21T00:00:00Z